Načítá se...
The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
In 2012, a novel approach to the treatment of Alzheimer’s disease was introduced, heralding a wave of excitement in the field of dementia. Bexarotene, a retinoid X receptor agonist, was shown to reverse neurodegeneration, improve cognition, and decrease levels of amyloid-β in transgenic mice express...
Uloženo v:
| Vydáno v: | Neuropsychiatr Dis Treat |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4327563/ https://ncbi.nlm.nih.gov/pubmed/25709453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S61309 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|